|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Echovirus IgG ELISA | ACTH ELISA Assay | Bevacizumab (Avastin®) ELISA | Epstein-Barr Virus (EBNA-1) IgG ELISA | PMN Elastase ELISA Assay |
| Catalog Number | IB05049 | BM7023 | TM09010 | IB79859 | IB79187 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgG antibodies directed against ECHO viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme-linked immunosorbent assay (ELISA) for the determination of ACTH (Adrenocorticotropic Hormone) in human plasma. 510(k) cleared. This assay is intended for in-vitro diagnostic use. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgG-class antibodies to Epstein-Barr virus nuclear antigen type 1 (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Solid phase enzyme immunometric assay (ELISA) for the determination of PMN elastase in EDTA or citrated plasma, exudate, bronchoalveolar lavage fluid, cerebrospinal fluid and seminal plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Echovirus IgG | Amyloid Beta (1-x) | Bevacizumab (Avastin®) | SCC | HE4 |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Blood Plasma, CSF, Serum, Cell Culture Media, Extract from Brain Tissue | Serum and plasma. | Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 5 to 165 pg/mL | 0 / 6 to 200 ng/mL | A cut-off control is used for the interpretation of results. | 15.6 to 1000 ng/mL |
| Sensitivity | > 95% | 3.55 pg/mL | 2 ng/mL | Inquire | < 25 pM. |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 4 hrs 30 mins (incubation) | 1 hour, 45 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hrs 20 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |